Oxford Biodynamics Takeover Rumours (OBD)

Big Pharma taking over monetizing on tests and leaving OBD to do science only is very obviously the best scenario as these results show all too clearly. Good at science, clueless at business. No idea how to treat shareholders as their rns's show. I won't bother to look at this crowd until there's news of a takeover in some form.